<DOC>
	<DOCNO>NCT00555477</DOCNO>
	<brief_summary>Women hormone-receptor positive breast cancer typically treat hormone therapy part treatment surgery . In past year find treatment aromatase inhibitor superior tamoxifen postmenopausal woman . Tamoxifen still use premenopausal woman , however , aromatase inhibitor effective woman function ovary . Some woman premenopausal time diagnose breast cancer , stop menstrual period treat chemotherapy . It unclear woman also treat safely aromatase inhibitor . In clinical trial researcher try answer question . Women hormone receptor positive breast cancer become postmenopausal chemotherapy invite participate study . Each woman treat one aromatase inhibitor , anastrozole ( Arimidex ) , carefully monitor ensure ovary start make estrogen . If estrogen level remain low , continue follow 18 month . If level increase level typically see premenopausal woman , however , stop take part study . The study also evaluate multiple factor may help doctor predict tolerate therapy without ovary start make estrogen . Some factor evaluate include hormone level ( blood test ) well family history early menopause ( mother , sister ) . In addition , change certain gene affect patient ' body handle chemotherapy drug test see affect whether patient recover ovarian function . Overall , purpose study determine patient become postmenopausal chemotherapy likely tolerate aromatase inhibitor treatment safely , often patient ' ovarian function need test treatment .</brief_summary>
	<brief_title>Aromatase Inhibitors Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>To eligible study : 1 . You must least 18 year age old 60 year age 2 . You breast cancer confine breast lymph node arm , evidence cancer elsewhere 3 . You must surgical removal tumor , indicate , radiation therapy must complete plan 4 . Your tumor must express estrogen and/or progesterone receptor 5 . You must menstrual period within 6 month start chemotherapy breast cancer . 6 . You must treat chemotherapy regimen include cyclophosphamide ( Cytoxan ) . Your menstrual period must stop least 8 week start chemotherapy . You eligible participate study : 1 . Your ovary surgically remove , treat radiation therapy , take medication ( Zoladex™ Lupron™ ) block function ovary .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>premenopausal breast cancer chemotherapy-induced ovarian failure</keyword>
</DOC>